No Difference in Behavioral and Self-Reported Outcomes for Simultaneous and Sequential Bilateral Cochlear Implantation: Evidence From a Multicenter Randomized Controlled Trial

Autor: Véronique J. C. Kraaijenga, Geerte G. J. Ramakers, Yvette E. Smulders, Alice van Zon, Rolien H. Free, Johan H. M. Frijns, Wendy J. Huinck, Robert J. Stokroos, Wilko Grolman
Přispěvatelé: Perceptual and Cognitive Neuroscience (PCN)
Rok vydání: 2019
Předmět:
Hearing aid
medicine.medical_specialty
QoL
Speech perception
Randomization
Hearing loss
Cost effectiveness
medicine.medical_treatment
bimodal
CHILDREN
simultaneous
Audiology
DUTCH
GUIDELINES
Sensory disorders Donders Center for Medical Neuroscience [Radboudumc 12]
law.invention
lcsh:RC321-571
COST-EFFECTIVENESS
03 medical and health sciences
0302 clinical medicine
All institutes and research themes of the Radboud University Medical Center
Randomized controlled trial
UTILITIES
law
QUALITY-OF-LIFE
BENEFITS
medicine
otorhinolaryngologic diseases
030223 otorhinolaryngology
GeneralLiterature_REFERENCE(e.g.
dictionaries
encyclopedias
glossaries)

lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
business.industry
General Neuroscience
ADULTS
SPEECH
medicine.disease
Clinical Trial
bilateral cochlear implantation
030220 oncology & carcinogenesis
Sensorineural hearing loss
medicine.symptom
business
sequential
Tinnitus
RCT
Neuroscience
Zdroj: Frontiers in Neuroscience, 13
Frontiers in Neuroscience, Vol 13 (2019)
Frontiers in Neuroscience, 13. FRONTIERS MEDIA SA
Frontiers in Neuroscience
Frontiers in Neuroscience, 13:54. Frontiers Media SA
ISSN: 1662-453X
Popis: Objective: The primary aim of this study was to longitudinally compare the behavioral and self-reported outcomes of simultaneous bilateral cochlear implantation (simBiCI) and sequential BiCI (seqBiCI) in adults with severe-to-profound postlingual sensorineural hearing loss.Design: This study is a multicenter randomized controlled trial with a 4-year follow-up period after the first moment of implantation. Participants were allocated by randomization to receive bilateral cochlear implants (CIs) either, simultaneously (simBiCI group) or sequentially with an inter-implant interval of 2 years (UCI/seqBiCI group). All sequential patients where encouraged to use their hearing aid on the non-implanted ear over of the first 2 years. Patients were followed-up on an annual basis. The primary outcome was speech perception in noise coming from a source directly in front of the patient. Other behavioral outcome measures were speech intelligibility-in-noise from spatially separated sources, localization and speech perception in quiet. Self-reported outcome measures encompassed questionnaires on quality of life, quality of hearing and tinnitus. All outcome measures were analyzed longitudinally using a linear or logistic regression analysis with an autoregressive residual covariance matrix (generalized estimating equations type).Results: Nineteen participants were randomly allocated to the simBiCI group and 19 participants to the UCI/seqBiCI group. Three participants in the UCI/seqBiCI group did not proceed with their second implantation and were therefore unavailable for follow-up. Both study groups performed equally well on speech perception in noise from a source directly in front of the patient longitudinally. During all 4 years of follow-up the UCI/seqBiCI group performed significantly worse compared to the simBiCI group on spatial speech perception in noise in the best performance situation (8.70 dB [3.96 – 13.44], p < 0.001) and localization abilities (largest difference 60 degrees configuration: -44.45% [-52.15 – -36.74], p < 0.0001). Furthermore, during all years of follow-up, the UCI/seqBiCI group performed significantly worse on quality of hearing and quality of life questionnaires. The years of unilateral CI use were the reason for the inferior results in the UCI/SeqBiCI group. One year after receiving CI2, the UCI/seqBiCI group performance did not statistically differ from the performance of the simBiCI group on all these outcomes. Furthermore, no longitudinal differences were seen in tinnitus burden prevalence between groups. Finally, the complications that occurred during this trial were infection, dysfunction of CI, facial nerve palsy, tinnitus and vertigo.Conclusion: This randomized controlled trial on bilaterally severely hearing impaired participants found a significantly worse longitudinal performance of UCI/seqBiCI compared to simBiCI on multiple behavioral and self-reported outcomes regarding speech perception in noise and localization abilities. This difference is associated with the inferior performance of the UCI/seqBiCI participants during the years of unilateral CI use. After receiving the second CI however, the performance of the UCI/seqBiCI group did not significantly differ from the simBiCI group.Trial Registration: Dutch Trial Register NTR1722.
Databáze: OpenAIRE